2020
Taking stock of vaccine hesitancy among migrants: a scoping review protocol
Tankwanchi AS, Jaca A, Larson HJ, Wiysonge CS, Vermund SH. Taking stock of vaccine hesitancy among migrants: a scoping review protocol. BMJ Open 2020, 10: e035225. PMID: 32404392, PMCID: PMC7228513, DOI: 10.1136/bmjopen-2019-035225.Peer-Reviewed Original ResearchConceptsVaccine-preventable diseasesVaccine hesitancySystematic reviewAllied Health LiteraturePeer-reviewed open access journalsAfrica-Wide InformationJoanna Briggs InstitutePreferred Reporting ItemsMeta-Analyses extensionWeb of ScienceWorld Health AssemblyScoping Reviews checklistCochrane LibraryVaccination servicesFull systematic reviewGlobal Action PlanCumulative IndexReporting ItemsEthical approvalComplementary medicineHealth LiteratureIndex MedicusReview protocolHealth AssemblyHesitancy
2017
Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America
Luque MT, Jenkins CA, Shepherd BE, Padgett D, Rouzier V, Succi RCM, Machado DM, McGowan CC, Vermund SH, Pinto JA. Mortality in Children with Human Immunodeficiency Virus Initiating Treatment: A Six-Cohort Study in Latin America. The Journal Of Pediatrics 2017, 182: 245-252.e1. PMID: 28081884, PMCID: PMC5328796, DOI: 10.1016/j.jpeds.2016.12.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveCause of DeathChildChild, PreschoolCohort StudiesConfidence IntervalsDatabases, FactualDose-Response Relationship, DrugDrug Administration ScheduleFemaleHIV InfectionsHumansIncidenceLatin AmericaMaleProportional Hazards ModelsRetrospective StudiesRisk AssessmentSeverity of Illness IndexSurvival AnalysisConceptsCombination antiretroviral therapyYears of ageCART initiationGreater riskCox proportional hazards modelAntiretroviral therapy-naïveMedian CD4 countRetrospective cohort studyProportional hazards modelCumulative mortality incidenceSouth America networkProbability of deathInitiating treatmentMedian CD4Antiretroviral therapyCause mortalityCD4 countTherapy-naïveCohort studyCumulative incidenceHIV epidemiologyPediatric careMortality incidenceHazards modelRegimens
2014
HIV and Noncommunicable Disease Comorbidities in the Era of Antiretroviral Therapy
Narayan KM, Miotti PG, Anand NP, Kline LM, Harmston C, Gulakowski R, Vermund SH. HIV and Noncommunicable Disease Comorbidities in the Era of Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 67: s2-s7. PMID: 25117958, DOI: 10.1097/qai.0000000000000267.Peer-Reviewed Original ResearchConceptsNoncommunicable diseasesChronic immune activationMedication side effectsAntiretroviral therapy programsSubstance use disordersNCD comorbidityAntiretroviral therapyMiddle-income countriesPulmonary diseaseImmune activationGenitourinary diseasesBone disordersDisease comorbiditiesSide effectsUse disordersTherapy programHIVDiseaseComorbiditiesInvestigator teamNutritional aspectsDisordersSaharan AfricaAging processCoinfection